New Treatments for Migraine

Update item information
Identifier 20190319_nanos_newinfo_1_05
Title New Treatments for Migraine
Creator Kathleen Digre, MD
Subject Migraine; Calcitonin Gene-Related Peptide; CGRP Receptor Antagonists; CGRP Monoclonal Antibodies; Device Therapies for Migraine
Description Migraine is very common-more common than diabetes and asthma combined. It affects almost 20% of women and 10% of men, and will make up a large number of people visiting a neuro-ophthalmology clinic. The World Health Organization has listed migraine in the top 10 most disabling conditions. Keeping up with advances in migraine pathophysiology and treatment is almost a full-time job, but every neuro-ophthalmologist must know about these new advances in treatment since individuals will be requesting medication or presenting with migraine in the neuro-ophthalmology clinic.
Relation is Part of NANOS Annual Meeting 2019: New Information I Should Know
Contributor Primary Kathleen Digre, MD
Publisher Spencer S. Eccles Health Sciences Library, University of Utah
Date 2019-03
Format video/mp4
Rights Management Copyright 2019. For further information regarding the rights to this collection, please visit:
Holding Institution North American Neuro-Ophthalmology Association. NANOS Executive Office 5841 Cedar Lake Road, Suite 204, Minneapolis, MN 55416
Language eng
ARK ark:/87278/s6vm8v8f
Setname ehsl_novel_nam
Date Created 2019-05-30
Date Modified 2019-07-01
ID 1427055
Reference URL
Back to Search Results